These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2952402)

  • 1. Secondary prevention of strokes: role of platelet antiaggregant drugs in diabetic and non-diabetic patients.
    Baudoin C; Bousser MG; Haguenau M; Lefauconnier JM; Eschwege E
    Diabet Med; 1985 Mar; 2(2):145. PubMed ID: 2952402
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiplatelet therapy and cerebrovascular diseases.
    Meloche JP
    Adv Otorhinolaryngol; 1982; 28():100-3. PubMed ID: 7051785
    [No Abstract]   [Full Text] [Related]  

  • 3. Aspirin and dipyridamole for the secondary prevention of stroke.
    Zielinski R; French L
    J Fam Pract; 1999 Feb; 48(2):92. PubMed ID: 10037534
    [No Abstract]   [Full Text] [Related]  

  • 4. Veterans Administration Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: II. Effects of aspirin and dipyridamole on atherosclerotic vascular disease rates.
    Colwell JA; Bingham SF; Abraira C; Anderson JW; Comstock JP; Kwaan HC; Nuttall F
    Diabetes Care; 1986; 9(2):140-8. PubMed ID: 3516608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does platelet antiaggregant therapy lessen the severity of stroke?
    Grotta JC; Lemak NA; Gary H; Fields WS; Vital D
    Neurology; 1985 May; 35(5):632-6. PubMed ID: 3887210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
    Rosendaal FR; Algra A
    J Neurol Sci; 1997 Sep; 150(1):85, 87. PubMed ID: 9260863
    [No Abstract]   [Full Text] [Related]  

  • 7. [Place of antiplatelet agents in the prevention of cerebral ischemic strokes].
    Bousser MG
    Ann Med Interne (Paris); 1983; 134(2):79-83. PubMed ID: 6349464
    [No Abstract]   [Full Text] [Related]  

  • 8. Secondary prevention of stroke: does dipyridamole add to aspirin?
    Lowenthal A; Buyse M
    Acta Neurol Belg; 1994; 94(1):24-34. PubMed ID: 8140884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet treatment in elderly people with transient ischaemic attacks or ischaemic strokes.
    Sivenius J; Riekkinen PJ; Laakso M
    BMJ; 1995 Jan; 310(6971):25-6. PubMed ID: 7827549
    [No Abstract]   [Full Text] [Related]  

  • 10. [Critical approach to a therapeutic trial in secondary prevention of cerebral ischemic accidents by antiaggregants].
    Guiraud-Chaumeil B
    Presse Med; 1983 Dec; 12(48):3045-8. PubMed ID: 6228912
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of dipyridamole in stroke prevention.
    Sivenius J; Diener HC
    Eur Neurol; 1996; 36(5):253-6. PubMed ID: 8864702
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti platelet agents for strokes and myocardial infarction: a critical appraisal of recent clinical trials.
    Castaldi PA
    Aust N Z J Med; 1981 Dec; 11(6):673-7. PubMed ID: 7036973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [2nd European study on secondary prevention of stroke (ESPS 2). Respective roles of acetylsalicylic acid, dipyridamole and their combination].
    Franck G
    Rev Med Liege; 1995 Nov; 50(11):491. PubMed ID: 8532998
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary prevention with aspirin in type 2 diabetic patients. Searching for the right spot.
    Manzano-Fernández S; Tello-Montoliu A; Marín F
    Circ J; 2012; 76(6):1333-4. PubMed ID: 22531598
    [No Abstract]   [Full Text] [Related]  

  • 15. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
    Sherry S
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782
    [No Abstract]   [Full Text] [Related]  

  • 17. [Large trials in the secondary prevention of stroke].
    Gensini GF; Simone I; Pantoni L; Inzitari D
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():102S-109S. PubMed ID: 9004808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of perioperative platelet inhibition on postcarotid endarterectomy mural thrombus formation. Results of a prospective randomized controlled trial using aspirin and dipyridamole in humans.
    Findlay JM; Lougheed WM; Gentili F; Walker PM; Glynn MF; Houle S
    J Neurosurg; 1985 Nov; 63(5):693-8. PubMed ID: 3903068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical appraisal of the clinical efficiency of anti-platelet drugs.
    Lecompte T; Samama M
    Agents Actions Suppl; 1986; 20():203-14. PubMed ID: 3544741
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of vascular complications after cerebral ischemia of arterial origin. European Stroke and Australian Stroke Prevention in Reversible Ischemia Trial (ESPRIT): moderated coagulation, aspirin-dipyridamole combination or aspirin alone?].
    De Schryver EL; Gorter JW; Algra A; van Gijn J
    Rev Med Interne; 1999 May; 20(5):397-9. PubMed ID: 10365408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.